• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全国性比较:日本患者的最佳腹膜透析结果

National comparisons: optimal peritoneal dialysis outcomes among Japanese patients.

作者信息

Kawaguchi Y

机构信息

Department of Nephrology and Hypertension, School of Medicine, Tokyo Jikei University, Japan.

出版信息

Perit Dial Int. 1999;19 Suppl 3:S9-16.

PMID:10433547
Abstract

This paper describes the current status of chronic dialysis in Japan and the guidelines used to initiate dialysis (scoring system), and reports the outcome of continuous ambulatory peritoneal dialysis (CAPD), focusing upon our center's experience. Fifty percent of CAPD technique survival was 6.9 +/- 1.3 years among those patients classified as "positive selection." The major causes of withdrawal from CAPD were ultrafiltration failure, the patients' inability to continue on CAPD by themselves, and peritonitis. The clinical issues that most concern nephrologists in CAPD management are prevention and management of ultrafiltration failure, prevention/therapeutic intervention in encapsulating peritoneal sclerosis, catheter-related infections, and prevention of underdialysis.

摘要

本文描述了日本慢性透析的现状以及用于启动透析的指南(评分系统),并报告了持续性非卧床腹膜透析(CAPD)的结果,重点是我们中心的经验。在那些被归类为“阳性选择”的患者中,CAPD技术生存率的50%为6.9±1.3年。退出CAPD的主要原因是超滤失败、患者自身无法继续进行CAPD以及腹膜炎。在CAPD管理中,肾脏科医生最关注的临床问题是超滤失败的预防和管理、包裹性腹膜硬化的预防/治疗干预、导管相关感染以及透析不足的预防。

相似文献

1
National comparisons: optimal peritoneal dialysis outcomes among Japanese patients.全国性比较:日本患者的最佳腹膜透析结果
Perit Dial Int. 1999;19 Suppl 3:S9-16.
2
Current status of peritoneal dialysis in Korea: efforts to achieve optimal outcome.韩国腹膜透析的现状:为实现最佳治疗效果所做的努力。
Perit Dial Int. 1999;19 Suppl 3:S17-25.
3
Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.持续性非卧床腹膜透析和持续性循环腹膜透析相关性腹膜炎
J Pediatr. 1984 Nov;105(5):726-30. doi: 10.1016/s0022-3476(84)80291-7.
4
Surgical aspects of continuous ambulatory peritoneal dialysis--3 years experience.持续性非卧床腹膜透析的手术相关情况——3年经验
Br J Surg. 1984 Mar;71(3):225-9. doi: 10.1002/bjs.1800710323.
5
Treatment failure in automated peritoneal dialysis and double-bag continuous ambulatory peritoneal dialysis.自动化腹膜透析和双联系统持续性不卧床腹膜透析治疗失败。
Nephrology (Carlton). 2013 Aug;18(8):545-8. doi: 10.1111/nep.12107.
6
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.在墨西哥一家腹膜透析中心,与持续性非卧床腹膜透析相比,接受自动化腹膜透析治疗的患者其患者/技术生存率及腹膜炎发生率得到改善。
Kidney Int Suppl. 2008 Apr(108):S76-80. doi: 10.1038/sj.ki.5002606.
7
Epidemiologic and demographic aspects of peritoneal dialysis in Mexico.墨西哥腹膜透析的流行病学和人口统计学特征
Perit Dial Int. 1996 Jul-Aug;16(4):362-5.
8
Peritonitis rates and common microorganisms in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.持续性非卧床腹膜透析和自动化腹膜透析中的腹膜炎发生率及常见微生物
Pediatr Int. 2009 Apr;51(2):246-9. doi: 10.1111/j.1442-200X.2008.02693.x.
9
Continuous cycling peritoneal dialysis versus CAPD peritonitis rates: statistically or clinically significant differences?持续循环腹膜透析与持续性非卧床腹膜透析的腹膜炎发生率:统计学差异还是临床显著差异?
Am J Kidney Dis. 2005 Jun;45(6):1144; author reply 1144-5. doi: 10.1053/j.ajkd.2005.03.017.
10
CAPD: an evolving technology in home dialysis.
Pride Inst J Long Term Home Health Care. 1984 Spring;3(2):20-6.

引用本文的文献

1
Effectiveness of Renin-Angiotensin-Aldosterone System Blockade on Residual Kidney Function and Peritoneal Membrane Function in Peritoneal Dialysis Patients: A Network Meta-Analysis.肾素-血管紧张素-醛固酮系统阻断剂对腹膜透析患者残余肾功能和腹膜功能的影响:一项网状荟萃分析。
Sci Rep. 2019 Dec 20;9(1):19582. doi: 10.1038/s41598-019-55561-5.
2
Changes in the worldwide epidemiology of peritoneal dialysis.腹膜透析的全球流行病学变化。
Nat Rev Nephrol. 2017 Feb;13(2):90-103. doi: 10.1038/nrneph.2016.181. Epub 2016 Dec 28.
3
Early Mortality Was Highly and Strongly Associated with Functional Status in Incident Japanese Hemodialysis Patients: A Cohort Study of the Large National Dialysis Registry.
早期死亡率与初诊日本血液透析患者的功能状态高度且密切相关:一项基于大型国家透析登记处的队列研究。
PLoS One. 2016 Jun 7;11(6):e0156951. doi: 10.1371/journal.pone.0156951. eCollection 2016.
4
Treatment for peritoneal dialysis-associated peritonitis.腹膜透析相关性腹膜炎的治疗
Cochrane Database Syst Rev. 2014 Apr 26;2014(4):CD005284. doi: 10.1002/14651858.CD005284.pub3.
5
Previous renal replacement therapy time at start of peritoneal dialysis independently impact on peritoneal membrane ultrafiltration failure.腹膜透析开始时既往肾脏替代治疗时间独立影响腹膜超滤失败。
Int J Nephrol. 2011;2011:685457. doi: 10.4061/2011/685457. Epub 2011 Sep 29.
6
Icodextrin: a review of its use in peritoneal dialysis.艾考糊精:其在腹膜透析中应用的综述
Drugs. 2003;63(19):2079-105. doi: 10.2165/00003495-200363190-00011.
7
Management of peritonitis in children receiving chronic peritoneal dialysis.接受慢性腹膜透析儿童腹膜炎的管理
Paediatr Drugs. 2003;5(5):315-25. doi: 10.2165/00128072-200305050-00004.